自用皮下注射系統－設備、市場、參與者及預測

Self-Administered On-Body Subcutaneous Infusion Systems - Devices, Markets, Players and Forecasts

出版日期: 2025年11月18日 | 出版商:

Greystone Research Associates | 英文 72 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

自用皮下注射技術是對推動醫療保健產業這一新興領域的技術、產品和參與者的全面評估和分析。本研究旨在為製藥決策者、藥物傳輸技術開發人員、醫療器材設計師、醫療保健行銷人員和供應鏈利益相關者提供關於護理點自註射和自用皮下注射設備的經濟性、技術性、疾病領域和商業機會的詳細了解。醫療保健高管、醫療保健管理人員和投資者也將從中獲得寶貴的見解。

推動皮下注射成長的融合因子

隨著預灌封設備在劑量和整體行業收入方面不斷取代小瓶，製藥和生物技術專案經理正越來越多地將注射器和自註射設備技術整合到他們的開發計劃中。這促使了多功能開發團隊的興起，以及對加速產品可行性測試的日益依賴。

本研究的洞見：

目前市面上或正在研發的門診皮下輸注系統有哪些？供應商有哪些？具體的設備規格是什麼？
家用皮下輸注系統面向哪些治療市場？
門診皮下輸注系統的基本設計要素、材料選擇挑戰、技術挑戰、市場開發挑戰是什麼？
推動便攜式皮下輸注系統需求的關鍵因素是什麼？
皮下輸注系統的潛在市場規模有多大？
皮下輸注系統對藥物輸送市場的預期影響為何？
該領域的主要參與者有哪些？他們的戰略是什麼？他們的聯盟夥伴有哪些？

研究方法

本研究方法是基於對主要市場參與者、技術開發商、經銷商、產業專家和市場影響者（包括監管機構、產業協會和材料標準組織）的深入訪談，以進行一手研究。

一手資料會根據二手資料進行評估和標準化，這些二手資料包括行業期刊文章、技術文獻、行業出版物、公司資料表、公開資訊以及來自政府機構和行業協會的統計資料。

市場需求和未來市場趨勢的預測和展望採用標準建模和統計技術得出。

綜合評估
目錄
摘要整理
注射/輸注市場區隔趨勢
藥物研發趨勢
給藥裝置的演變
患者自我給藥趨勢
使能技術
冷凍乾燥藥物/復溶
皮下輸注系統 - 設計因素
容量和黏度
初級包裝
輸注法
裝置電子元件
皮下輸注裝置 - 市場區隔
門診輸注成本與物流負擔
生物製劑
大容量藥物
持續時間相關因素藥物
皮下輸注系統設備分析
enFuse（Enable Injections）
Libertas（Becton Dickinson）
Evolve（Becton Dickinson）
SensePatch（Sensile Medical/Gerresheimer）
SmartDose（West Pharmaceuticals）
SmartDose Preload（West Pharmaceuticals）
非品牌器材（Sorrel Medical）
非品牌設備（Subject）
YpsoDose（Ypsomed）
E3D 貼片幫浦（Elcam）
Pods（Stevanato）
市場因素
自我給藥與病人依從性
監管指南和產品審批
衛生經濟學
藥物差異化
市場參與者概況

簡介目錄

Self-administered On-Body Subcutaneous Infusion is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for devices that can self-administer injectable/infusible drugs subcutaneously at the point-of-care. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Converging Factors Driving the Growth of Subcutaneous Infusion

As prefilled devices continue to replace vials in terms of doses as well as total sector revenue, pharmaceutical and biotech program managers are increasingly integrating syringe and self-injection device technology into their development plans. The result has been a migration toward multi-functional development teams and an increasing reliance on accelerated product feasibility testing.

What You Will Learn:

What ambulatory subcutaneous infusion systems are currently marketed or in development, who are the suppliers, and what are the device specifics?
What are the therapeutic markets being targeted by ambulatory subcutaneous infusion systems?
What are the essential design factors, material selection issues, technologies and market development issues for ambulatory subcutaneous infusion systems?
What are the major factors that will drive ambulatory subcutaneous infusion systems demand?
What is the addressable market for subcutaneous infusion systems?
What is the expected impact of subcutaneous infusion systems on drug delivery markets?
Who are the significant players in this segment? What are their strategies? Who are their alliance partners?

Methodology

Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations.

Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations.

Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques.